Company Reports (Pharmaceutical) Market Research

Discover indepth market information on companies in Pharma & Healthcare. Our catalogue of reports provide detailed data on companies such as Wyeth, AstraZeneca Plc, Illumina Inc, and Johnson & Johnson.

Stay up-to-date with new products added to this category

Results 901 - 1000 of 5395 go to 1st page

first

previous 5 6 7 8 9 10 11 12 13 14 15 next

last

Title	Date	Price
Cambrex Corp.-Deals & Alliances Report	Sep 2009	£380
Capstone Therapeutics-Therapeutic Competitors	Sep 2009	£220
China Aoxing Pharmaceutical Co., Inc.-Detailed Product Pipeline	Sep 2009	£475
Columbia Laboratories Inc-Detailed Product Pipeline	Sep 2009	£475
Cubist Pharmaceuticals Inc.-Deals & Alliances Report	Sep 2009	£380
Canopus BioPharma, Inc.-Company Report	Sep 2009	£475
BioSpecifics Technologies Corp-Therapeutic Competitors	Sep 2009	£220
Bruker Corporation-Deals & Alliances Report	Sep 2009	£380
Benda Pharmaceutical, Inc-Therapeutic Competitors	Sep 2009	£220
BrainCells Inc.-Company Report	Sep 2009	£475
Brookes Pharmaceutical Laboratories (Pakistan) Limited-Company Report	Sep 2009	£475
Cordex Pharma, Inc.-Detailed Product Pipeline	Sep 2009	£475
Cenomed BioSciences, LLC-Company Report	Sep 2009	£475
CLL PHARMA-Company Report	Sep 2009	£475
Colgate-Palmolive Co.-Therapeutic Competitors	Sep 2009	£220
Clinical Data Inc-Detailed Product Pipeline	Sep 2009	£475
Clarient, Inc.-Deals & Alliances Report	Sep 2009	£380
Celsion Corp-Detailed Product Pipeline	Sep 2009	£475
Chromocell Corporation-Company Report	Sep 2009	£475
Circassia Holdings Ltd.-Company Report	Sep 2009	£475
Cerep-Company Report	Sep 2009	£475
Compugen Ltd-Detailed Product Pipeline	Sep 2009	£475
China Shineway Pharmaceutical Group Limited-Company Report	Sep 2009	£475
Choongwae Pharma Corporation-Company Report	Sep 2009	£475
BioSante Pharmaceuticals, Inc.-Deals & Alliances Report	Sep 2009	£380
BioSante Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
AXM Pharma Inc-Detailed Product Pipeline	Sep 2009	£475
AVAX TECHNOLOGIES INCORPORATED-Detailed Product Pipeline	Sep 2009	£475
Banyu Pharmaceutical Co.,Ltd.-Company Report	Sep 2009	£475
Baxter International Inc.-Deals & Alliances Report	Sep 2009	£380
BexCore Inc.-Company Report	Sep 2009	£475
Avontec GmbH-Company Report	Sep 2009	£475
Avitar Inc.-Deals & Alliances Report	Sep 2009	£380
Aurobindo Pharma Ltd.-Company Report	Sep 2009	£475
AVEO Pharmaceuticals, Inc. (formerly GenPath Pharmaceuticals, Inc.)-Company Report	Sep 2009	£475
Avila Therapeutics, Inc.-Company Report	Sep 2009	£475
Avigen Inc-Detailed Product Pipeline	Sep 2009	£475
BioCryst Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
BioForce Nanosciences Holdings, Inc.-Deals & Alliances Report	Sep 2009	£380
BELLUS Health Inc.-Deals & Alliances Report	Sep 2009	£380
BioMarin Pharmaceutical Inc.-Deals & Alliances Report	Sep 2009	£380
Bristol-Myers Squibb Company-Detailed Product Pipeline	Sep 2009	£475
Boryung Pharmaceutical Company, Ltd.-Company Report	Sep 2009	£475
BioMarin Pharmaceutical Inc-Detailed Product Pipeline	Sep 2009	£475
Immucor Inc.-Deals & Alliances Report	Sep 2009	£380
Bioheart, Inc.-Therapeutic Competitors	Sep 2009	£220
Bio-Bridge Science Inc-Therapeutic Competitors	Sep 2009	£220
BIOCODEX-Company Report	Sep 2009	£475
BioXell S.p.A.-Company Report	Sep 2009	£475
Corgenix Medical Corp.-Deals & Alliances Report	Sep 2009	£380
CorePharma LLC-Company Report	Sep 2009	£475
Dnaprint Genomics Inc-Therapeutic Competitors	Sep 2009	£210
Digna Biotech, S.L.-Company Report	Sep 2009	£455
Dov Pharmaceutical Inc-Detailed Product Pipeline	Sep 2009	£455
DOR BioPharma Inc-Detailed Product Pipeline	Sep 2009	£455
DURECT Corporation-Detailed Product Pipeline	Sep 2009	£455
DATATRAK International, Inc.-Deals & Alliances Report	Sep 2009	£360
Deciphera Pharmaceuticals, LLC-Company Report	Sep 2009	£455
DAWA Limited-Company Report	Sep 2009	£455
Daana Pharmaceutical Company-Company Report	Sep 2009	£455
Daihan Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
deCODE genetics Inc-Detailed Product Pipeline	Sep 2009	£455
Derma Sciences Inc-Detailed Product Pipeline	Sep 2009	£455
Dragon Pharmaceutical Inc-Detailed Product Pipeline	Sep 2009	£455
Echo Therapeutics, Inc-Detailed Product Pipeline	Sep 2009	£455
Elan Corp Plc-Detailed Product Pipeline	Sep 2009	£455
Eczacibasi-Zentiva-Company Report	Sep 2009	£455
Elite Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£455
Dyax Corp-Detailed Product Pipeline	Sep 2009	£455
Emergent BioSolutions Inc-Detailed Product Pipeline	Sep 2009	£455
Discovery Laboratories Inc-Detailed Product Pipeline	Sep 2009	£455
Dream Pharma Corp.-Company Report	Sep 2009	£455
DUSA Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£455
Dynavax Technologies Corp-Detailed Product Pipeline	Sep 2009	£455
DARA BioSciences, Inc-Detailed Product Pipeline	Sep 2009	£455
CytRx Corporation-Detailed Product Pipeline	Sep 2009	£455
Celera Corporation-Deals & Alliances Report	Sep 2009	£380
CuraGen Corp-Therapeutic Competitors	Sep 2009	£220
Critical Outcome Technologies, Inc-Company Report	Sep 2009	£475
Champions Biotechnology, Inc.-Therapeutic Competitors	Sep 2009	£220
China Sky One Medical, Inc.-Detailed Product Pipeline	Sep 2009	£475
Cepheid-Deals & Alliances Report	Sep 2009	£380
Caraco Pharmaceutical Laboratories Ltd-Detailed Product Pipeline	Sep 2009	£475
CORIA Laboratories, Ltd.-Company Report	Sep 2009	£475
Corcept Therapeutics Inc-Detailed Product Pipeline	Sep 2009	£475
Covalon Technologies Ltd.-Company Report	Sep 2009	£475
CPEX Pharmaceuticals, Inc.-Detailed Product Pipeline	Sep 2009	£475
Champions Biotechnology, Inc.-Detailed Product Pipeline	Sep 2009	£475
CrystalGenomics, Inc.-Company Report	Sep 2009	£475
CytoDyn Inc-Detailed Product Pipeline	Sep 2009	£455
Cyclacel Pharmaceuticals, Inc.-Therapeutic Competitors	Sep 2009	£210
Cytokine PharmaSciences Inc.-Company Report	Sep 2009	£455
Cypress Pharmaceutical, Inc.-Company Report	Sep 2009	£455
Cyanotech Corporation-Detailed Product Pipeline	Sep 2009	£475
CVS Caremark Corporation-Deals & Alliances Report	Sep 2009	£380
Neuralstem Inc.-Detailed Product Pipeline	Sep 2009	£475
Curacyte AG-Company Report	Sep 2009	£475
CardioVascular BioTherapeutics Inc-Detailed Product Pipeline	Sep 2009	£475
CEL-SCI Corporation-Therapeutic Competitors	Sep 2009	£220
Emisphere Technologies Inc-Detailed Product Pipeline	Sep 2009	£455